larynx and pharynx cancer
Home Up Normal organs Evaluation slide (TEST SLIDE) Various cancers Normal organs and cancers prostate cancer Breast: cancer-metastasis-normal lung cancer Lung: cancer-metastasis-normal Normal lung tissue colon and rectum cancer colorectal: cancer-metastasis-normal Normal colon and rectum tissue larynx and pharynx cancer Ovary cancer Kidney cancer Stomach cancer Normal stomach tissue Esophagus cancer Liver cancer Liver: cancer-metastasis-normal Non-neoplastic liver tissue Thyroid cancer Lipomatous tumors Skin cancer Normal endometrium

 

 


 
   Category Human tissue array
   Cat. No. CH
   Product description larynx and pharynx cancer
   Data sheet CH1xls
CH1
    
   Images
  general_information
   No. of samples 60
   Text
Current version: CH1
larynx or pharynx cancer: 60 cores

Price : 5 slide for 600 €

CH1   Human larynx and pharynx cancer
             
  Age Sex Location Diagnosis TNM Stage
1 43 M larynx, pyriform sinus  SCC*, moderately differentiated T4N2M0 ⅣA
2 55 M larynx, subglottic SCC, moderately differentiated T4N0M0 ⅣA
3 72 M larynx, supraglottic SCC, moderately differentiated T3N0M0
4 63 M esophagus SCC, basaloid type T4N0M0 ⅣA
5 67 M larynx, transglottic SCC, well differentiated T4N2bM0 ⅣA
6 63 M larynx, pyriform sinus SCC, moderately differentiated T4N2cM0 ⅣA
7 60 M larynx, supraglottic SCC, moderately differentiated T4N2cM0 ⅣA
8 61 M larynx, glottic SCC, moderately differentiated T4N0M0 ⅣA
9 66 M larynx, glottic SCC, moderately differentiated T4N0M0 ⅣA
10 56 M larynx, glottic SCC, well differentiated T1N0M0
11 62 M larynx, supraglottic SCC, moderately differentiated T3N2M0 ⅣA
12 56 M larynx, pyriform sinus  SCC, moderately differentiated T4N2bM0 ⅣA
13 54 M larynx, supraglottic SCC, well differentiated T3N0M0
14 48 M larynx, transglottic SCC, well differentiated T3N0M0
15 61 M larynx, supraglottic SCC, well differentiated T3N0M0
16 66 M soft tissue of neck SCC, well differentiated of hypopharynx T4N0M0
17 51 M larynx, supraglottic SCC, moderately differentiated T4N2cM0 ⅣA
18 46 M soft tissue, neck SCC of hypopharynx T2N3M0 ⅣB
19 52 M larynx, supraglottic SCC, moderately differentiated T2N0M0
20 52 F Nasal cavity undifferentiated carcinoma T4NxM0 ⅣA
21 64 M larynx, transglottic basaloid SCC T3N1M0
22 28 F lymph node undifferentiated carcinoma from nasopharynx T1N2cMx 0
23 63 M Nasopharynx undifferentiated carcinoma TxN2M1 ⅣC
24 77 M Neck undifferentiated carcinoma TxN2M0 ⅣA
25 51 M larynx, transglottic SCC, well differentiated T4N2M0 ⅣA
26 51 M hypopharynx SCC, moderately differentiated TxN1M0
27 59 M nasal cavity SCC, poorly differentiated T4N0M0 ⅣA
28 55 M larynx, subglottic SCC, moderately differentiated T3N0M0
29 60 M larynx, transglottic Larynx, SCC, well differentiated T4N0M0 ⅣA
30 70 M oropharynx undifferentiated carcinoma T1N2aM0 ⅣA
31 55 M hypopharynx squamous cell carcinoma, poorly differentiated T4N2bM0 ⅣA
32 62 M larynx, pyriform sinus SCC T3N0M0
33 48 M soft tissue, neck SCC from larynx T2N1M0
34 66 M larynx, supraglottic SCC, moderately differentiated T4N2bM0 ⅣA
35 58 M larynx, transglottic SCC, well differentiated T3N0M0
36 76 M larynx, supraglottic SCC, moderately differentiated T3N1M0
37 61 M larynx, supraglottic SCC, well differentiated T4N2bM0 ⅣA
38 66 M submandibular gland undifferentiated ca. with lymphoid stroma T3N2M0
39 54 M tonsil SCC, poorly differentiated T2N2bM0 ⅣA
40 61 M nose SCC, poorly differentiated T3N0M0
41 65 M larynx, glottic Larynx, SCC, moderately differentiated T4NxM1 ⅣC
42 54 M skin, neck undifferentiated carcinoma from nasopharynx T4N2aM0 ⅣA
43 82 F larynx, supraglottic SCC, moderately differentiated T3N1M0
44 56 M larynx, subglottic SCC T4N2bM0 ⅣA
45 75 M larynx, transglottic SCC, well differentiated T4N0M0 ⅣA
46 69 M larynx, glottic SCC, poorly differentiated T4N2bM0 ⅣA
47 43 M larynx, subglottic SCC, moderately differentiated T3N0M0
48 60 M larynx, glottic SCC T4N0M0 ⅣA
49 66 M larynx, supraglottic SCC, poorly differentiated T2N0M0
50 34 F breast medullary carcinoma TNM 0
51 58 M larynx, pyriform sinus SCC T3N2bM0 ⅣA
52 47 F maxilla undifferentiated carcinoma T1N0M0
53 65 M larynx, glottic SCC, well differentiated T4N2M0 ⅣA
54 78 M larynx, supraglottic SCC, moderately differentiated T4N1M0 ⅣA
55 69 M epiglottis basaloid SCC T2N0M0
56 60 M epiglottis SCC, moderately differentiated T2N3M0 ⅣB
57 46 F lymph node, neck undifferentiated ca., primary site unknown TNM 0
58 70 M larynx, glottic SCC, poorly differentiated T4N2M0 ⅣA
59 79 M larynx, supraglottic SCC, poorly differentiated T3N2bM0 ⅣA
60 52 M larynx, supraglottic SCC T3N1M0
             
*SCC: squamous cell carcinoma      
TNM and stage classification : larynx and pharynx cancer (AJCC 5th Edition)    

General Information of the Tissue Array Slide :

Applications

  • 􀁺 Immunohistochemistry
  • 􀁺 In situ hybridization, RNA or DNA
  • 􀁺 Fluorescent in situ hybridization (FISH)
  • 􀁺 In situ PCR, RNA or DNA
  • 􀁺 TUNEL for apoptosis (Recommended procedures in www.tissue-array.com -> protocol)

Storage and stability

  • 􀁺 Individual slide is paraffin-coated and put in an air-tight pack with inert gas.
  • 􀁺 Tissue array slides are shipped in room temperature.
  • 􀁺 If the slides are stored in 4 degree, they are good up to one year.

How processed

  • 􀁺 Tissues were initially fixed with formalin except for some of the animal tissues.
  • 􀁺 Then, dehydrated with gradient ethanol; typically 1 hour each progressive steps; 70%, 90%, 95%, 99%, 100% x 3 times.
  • 􀁺 Cleared by xylene, three changes for 1 hour each.
  • 􀁺 Infiltrated with 60°C paraffin, three changes for 1 hour each
  • 􀁺 Microtoming in 4 µm thickness and put on silane coating slide from Muto Pure Chemicals (Japan)

Before use

  • 􀁺 Dry slides for 1 hour in a oven at 60 degree.
  • 􀁺 Dewax slides in xylene for 4 minutes x 5 times
  • 􀁺 Hydrate slides in 100%, 95% and 75% ethanol for 3 minutes x 2 times each.
  • 􀁺 Immerse slides in tap water for 5 minutes

Slide orientation

  • 􀁺 In most of the slides with 59 or 60 cores, the orientation is as below unless indicated otherwise. #60 location is usually filled with carbon for orientation.

Shaded area

1 2 3 4 5 6 7 8 9 10
11 12 13 14 15 16 17 18 19 20
21 22 23 24 25 26 27 28 29 30
31 32 33 34 35 36 37 38 39 40
41 42 43 44 45 46 47 48 49 50
51 52 53 54 55 56 57 58 59 60